This study is currently not recruiting participants.

Patient Perspectives on HIV Cure

Understanding Acceptability of Risks and Benefits in HIV Cure Trials

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to understand acceptability of risks and benefits of participation in HIV curative clinical trials and cure therapy among persons living with HIV in the US and to evaluate if patient characteristic impact the acceptability.

Detailed description of study

The purpose of this study is to understand acceptability of risks and benefits of participation in HIV curative clinical trials and cure therapy among persons living with HIV in the US and to evaluate if patient characteristic impact the acceptability.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: HIV
  • Age: 100 years or below
  • Gender: All

This study investigates the acceptability of risks and benefits associated with participating in HIV curative clinical trials among people living with HIV in the United States. It aims to understand how different patient characteristics might influence this acceptability.

Participants will be asked about their views on potential risks and benefits of HIV cure therapies. The study will collect information through surveys or interviews to gather insights into their perspectives.

  • Who can participate: The study is open to individuals aged 18 and older living with HIV in the United States.
  • Study details: Participants will be involved in surveys or interviews to share their perspectives on HIV cure therapies. A placebo is not involved in this study.
Updated on 19 Feb 2024. Study ID: 1707267034

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team